skip to main content

Sponsored by the Intensive Short Term Dynamic Psychotherapy Faculty

Hope and Healing: Working with Treatment Resistant Depression Using ISTDP

Joel Town, PhD

Saturday-Sunday, Sept. 8-9, 2018, 9AM-5:15PM

Presentations by Dr. Town, Saturday and Sunday.
Presentation by Maury Joseph, PsyD on Sunday.

(Registration and continental breakfast, 8:30-9)

Fees and Continuing Education Credits (credit hours)

For Saturday and Sunday, 12 CE/CME

Regular $300

By Member Level:

Contributing $240
Sustaining $210
Silver $195
Gold $180

Current WSP Students $100

At the Washington School of Psychiatry, 5028 Wisconsin Ave #400 Washington DC 20016


Over half of people suffering with major depression do not report an adequate response to front line treatment efforts. With each unsuccessful treatment, the prognosis becomes worse leading to demoralization in both patients and professionals. Published research from the Halifax Depression Study demonstrates the long-term efficacy of Intensive Short-Term Dynamic Psychotherapy (ISTDP) for treatment resistant depression. New findings also suggest how therapists can enhance their treatments by better understanding the times in therapy when helping patients to experience their emotions will be most effective.

This 2-day training course will focus on the method of ISTDP for treatment resistant depression. Detailed analysis of audio-visual case material will illustrate central principles therapists can use for helping their patients to overcome processes linked to treatment resistance.

Learning Objectives:

  • 1. Identify 3 psychological processes that can create treatment resistance in depressed patients
  • 2. Identify 3 signals of unconscious anxiety that can inform timing and validity of interventions
  • 3. Summarize empirical evidence for ISTDP for treatment resistant depression
  • 4. Outline key treatment phases for ISTDP treatment
  • 5. Identify and reflect on therapist and training factors contributing to effective treatment for treatment resistant depression
  • 6. Identify strategies for enhancing your delivery of ISTDP for treatment resistant populations


Dr. Joel Town is a Clinical Psychologist and Assistant Professor at the Centre for Emotions & Health, Dalhousie University, Canada. He has published widely on the efficacy of short-term psychodynamic therapies and therapeutic processes associated to change. He is the primary investigator on two clinical trials exploring the efficacy of ISTDP for somatic symptom disorders and treatment resistant depression. In his clinical practice, Dr. Town specializes in treating refractory populations, specifically post-traumatic stress disorder, somatic symptoms and depression.

Maury Joseph, PsyD ( is a psychologist in Washington, DC, specializing in treatment-resistant depression and anxiety, and medically unexplained physical symptoms. He is co-founder of the Institute for Emotions and Health in DC, a practice focused on diagnosis, treatment, and research of medically unexplained physical symptoms. He is chair of the ISTDP training program at the Washington School of Psychiatry, and serves as an assistant clinical faculty member at George Washington University and adjunct faculty at The Chicago School of Professional Psychology.



Cancellations and Refunds

Refunds will be made for cancellations received at the School office in writing at least 10 days before the seminar date and are subject to a non-refundable administrative fee of $50.

Who should attend?

The workshop is intended for psychologists, psychiatrists, social workers, psychiatric nurses, licensed professional counselors, marriage and family therapists, physicians, medical students, and other graduate students.


The Washington School of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Washington School of Psychiatry maintains responsibility for this program and its content.

The School is approved by the Social Work Board of the State of Maryland as a provider of continuing education for social workers in DC, MD, VA and WV.

The Washington School of Psychiatry has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6388. Programs that do not qualify for NBCC credit are clearly identified. The Washington School of Psychiatry is solely responsible for all aspects of the program.

The School is accredited by MedChi, The Maryland State Medical Society to provide continuing medical education for physicians.

The School designates each session for a maximum of 15_ AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support and the Unlabeled use of a commercial product. No member of the planning committee and no member of the faculty for this event have a financial interest or other relationship with any commercial product.